Cannabics Pharmaceuticals Inc.
Rank 68
About
Based in the US, Cannabics Pharmaceuticals focus is the use of tailored cannabinoid-based therapies to support cancer patients. In conjunction with artificial intelligence and drug screening tools, they aim to provide a personalised service. A licensed facility in Israel conducts research and development. Their central office is based in Bethesda, Maryland.
$0.2435
USD
2.53%
Market cap
$32,892,087
Total volume
$26,235
Shares outstanding
135,080,441
Reserved shares
764,919,559
Rank 68
About
Based in the US, Cannabics Pharmaceuticals focus is the use of tailored cannabinoid-based therapies to support cancer patients. In conjunction with artificial intelligence and drug screening tools, they aim to provide a personalised service. A licensed facility in Israel conducts research and development. Their central office is based in Bethesda, Maryland.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
CNBX |
$26,235
|
100% |
$0.2435
|
Chart